Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations (India) Share Price Rises 8.82% Today
- August 28, 2026
- Posted by: Harsh Piplani
- Category: News
Syncom Formulations (India) Share Price rose to Rs 18.88 today, up 8.82% from the previous close of Rs 17.35, with market capitalisation at Rs 1,600.82 crore. The move places Syncom Formulations (India) Ltd. among the notable stocks in news on a day when Stock Market Today and Share Market Today screens are watching healthcare names closely. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Syncom Formulations (India) Share Price Today on Univest, the most relevant context is the day’s price action, turnover of Rs 2.49 crore, and the valuation and peer backdrop that follow below.
Syncom Formulations (India) Stock News is relevant today because the share price moved within a narrow intraday band between Rs 17.35 and Rs 19.35, ending near the upper end of that range. The stock opened at Rs 17.64 and added Rs 1.53 on the day. Univest notes that this is a factual share price rise, not a disclosed-event story, so the focus stays on measurable market data, fundamental ratios, and industry comparison.
Syncom Formulations (India) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 18.88 |
| Previous Close | Rs 17.35 |
| Today's Move | Rs 1.53 (+8.82%) |
| Open | Rs 17.64 |
| High | Rs 19.35 |
| Low | Rs 17.35 |
| Turnover | Rs 2.49 crore |
| Market Capitalisation | Rs 1,600.82 crore |
| Market Cap Category | Small Cap |
Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 18.88 from the previous close of Rs 17.35, a move of Rs 1.53 or 8.82%. The stock opened at Rs 17.64, reached a high of Rs 19.35, recorded a low of Rs 17.35.
Syncom Formulations (India) Share Price Today reflects a same-day gain of 8.82%, taking the stock from Rs 17.35 at the previous close to Rs 18.88. The day’s low matched the previous close at Rs 17.35, while the high reached Rs 19.35, showing an intraday range of Rs 2.00. The stock opened at Rs 17.64 and closed above the open, which is consistent with a positive price day based on the reported figures. Turnover stood at Rs 2.49 crore, giving a factual measure of traded value alongside the price rise. Univest records this as a clear share price rise in Syncom Formulations (India) Stock News, while the data supplied for the day does not establish a specific corporate trigger.
Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,600.82 crore |
| P/E Ratio | 19.22x |
| P/B Ratio | 3.73x |
| ROE | 15.69% |
| ROCE | 18.77% |
| EPS | Rs 0.9 |
| Book Value Per Share | Rs 4.65 |
| Dividend Yield | 0% |
Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P/E 19.22x, P/B 3.73x, ROE 15.69%, ROCE 18.77%. These figures provide context only and are not a buy or sell signal.
Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1600.82 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 19.22x, P/B at 3.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.69% and ROCE of 18.77%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 0.9, book value per share of Rs 4.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.16x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 19.22x |
| Benchmark Median P/E | 31.16x |
| Benchmark Average P/E | 48.05x |
| Benchmark P/E Range | 3.36x to 397.25x |
| Company P/B Ratio | 3.73x |
| Benchmark Median P/B | 2.71x |
| Company ROE | 15.69% |
| Benchmark Median ROE | 11.82% |
| Company ROCE | 18.77% |
| Benchmark Median ROCE | 13.71% |
| Company Market Capitalisation | Rs 1,600.82 crore |
| Benchmark Median Market Cap | Rs 664.09 crore |
Syncom Formulations (India) Ltd. (SYNCOMF) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 19.22x, which is below the benchmark median of 31.16x, a difference of -38.32%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 15.69%, which is above the benchmark median of 11.82%, a difference of +32.74%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 18.77%, which is above the benchmark median of 13.71%, a difference of +36.91%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,56,113.58 | 37.7 | 5.27 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,39,321.25 | 82.14 | 13.6 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,85,923.81 | 87.64 | 21.3 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,14,508.45 | 26.28 | 4.4 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,13,778.04 | 34.03 | 3.26 | 11.83 | 16 |
Syncom Formulations (India) Ltd. (SYNCOMF) has a P/E ratio of 19.22x compared with the displayed peer median of 37.7x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 15.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.77% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,600.82 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Syncom Formulations (India)
- Syncom Formulations (India) Share Price rose 8.82% today to Rs 18.88, with a day change of Rs 1.53.
- The intraday range was Rs 17.35 to Rs 19.35, with the stock closing above the open of Rs 17.64.
- Market capitalisation stood at Rs 1,600.82 crore, above the sector median of Rs 664.09 crore.
- P/E of 19.22 is below the same-industry median P/E of 31.16 across 201 companies.
- ROE of 15.69% and ROCE of 18.77% are both above the same-industry medians in the benchmark set.
About Syncom Formulations (India)
Syncom Formulations (India) Ltd. is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The company operates in a segment that is closely followed for pricing, valuation and profitability trends on NSE and BSE. Based on the supplied data, the most visible company identifiers for today are its share price, market capitalisation and valuation ratios rather than a disclosed event-based catalyst.
For readers comparing Syncom Formulations (India) Share Price with broader pharmaceutical names, the company’s exact financial snapshot matters: EPS of Rs 0.90, book value of Rs 4.65, dividend yield of 0, ROE of 15.69% and ROCE of 18.77%. These figures help explain the stock’s financial profile in a plain, measurable way. On Univest, this company overview sits alongside live price, shareholding pattern and benchmark context so the stock can be followed in one place.
Track Syncom Formulations (India) Share Price on Univest
Use Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Syncom Formulations (India) Share Price Live on Univest for the latest price update, market cap, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Syncom Formulations (India) Stock Analysis, company news and sector comparison in one view for easier follow-up.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Syncom Formulations (India) Share Price rise today?
Ans. The supplied data confirms a same-day price rise, but it does not establish a company-specific catalyst. Syncom Formulations (India) Share Price moved from Rs 17.35 to Rs 18.88, which is an 8.82% gain on the day.
What is Syncom Formulations (India) Share Price today?
Ans. Syncom Formulations (India) Share Price today is Rs 18.88. The stock added Rs 1.53 from the previous close of Rs 17.35, and the move was accompanied by turnover of Rs 2.49 crore.
What does Syncom Formulations (India) Stock News show today?
Ans. Syncom Formulations (India) Stock News shows a positive price day with a close near the upper end of the intraday range. The stock traded between Rs 17.35 and Rs 19.35 before ending at Rs 18.88.
How is Syncom Formulations (India) valued on a fundamental basis?
Ans. Syncom Formulations (India) Share Price is backed by a P/E of 19.22, P/B of 3.73, EPS of Rs 0.90 and book value of Rs 4.65. Dividend yield is 0, while ROE and ROCE are 15.69% and 18.77%.
How does Syncom Formulations (India) compare with its sector benchmark?
Ans. In the same-industry benchmark of 201 companies, Syncom Formulations (India) has a lower P/E than the median and average, a higher ROE than both, and a higher ROCE than both. Its market cap is also above the sector median.
How does Syncom Formulations (India) compare with listed peers?
Ans. Syncom Formulations (India) Share Price is accompanied by a smaller market cap than the supplied large peers, but its P/E is lower than all five compared names. Its ROE and ROCE sit in the middle of the peer set.
What is the market capitalisation of Syncom Formulations (India)?
Ans. Syncom Formulations (India) has a market capitalisation of Rs 1,600.82 crore. That is above the same-industry median market cap of Rs 664.09 crore and well below the benchmark average of Rs 13,883.33 crore.
Where can I track Syncom Formulations (India) Share Price Live?
Ans. You can track Syncom Formulations (India) Share Price Live on Univest, where the stock page brings together current price, valuation ratios, sector context, peer comparison and shareholding information in one view.
